The Current Ratio as of November 2024 (TTM) for Haleon plc (HLN) is 0.84

According to Haleon plc’s latest financial reports and current stock price. The company's current Current Ratio is 0.84. This represents a change of 78.58% compared to the average of 0.47 of the last 4 quarters.

Haleon plc (HLN) Historical Current Ratio (quarterly & annually)

How has HLN Current Ratio performed in the past?

The mean historical Current Ratio of Haleon plc over the last ten years is 1.16. The current 0.84 Current Ratio has changed 7.10% with respect to the historical average. Over the past ten years (40 quarters), HLN's Current Ratio was at its highest in in the June 2022 quarter at 3.43. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

Haleon plc (HLN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Haleon plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Haleon plc (HLN) Average Current Ratio

How has HLN Current Ratio performed in the past?

The current Current Ratio of Haleon plc (HLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Haleon plc (HLN) Current Ratio vs. Peers

How is HLN’s Current Ratio compared to its peers?

Haleon plc’s Current Ratio is less than Teva Pharmaceutical Industries Limited (0.89), less than Bausch Health Companies Inc. (1.19), less than Zoetis Inc. (3.69), less than Takeda Pharmaceutical Company Limited (1.28), less than Dr. Reddy's Laboratories Limited (1.92), less than Emergent BioSolutions Inc. (2.88), less than HUTCHMED (China) Limited (2.81), less than Viatris Inc. (1.51), less than PetIQ, Inc. (2.58), less than Neurocrine Biosciences, Inc. (4.37), less than Elanco Animal Health Incorporated (2.55), less than Catalent, Inc. (2.51), less than Lantheus Holdings, Inc. (1.65), less than SIGA Technologies, Inc. (8.10), greater than Indivior PLC (0.83), less than Esperion Therapeutics, Inc. (1.85),

Build a custom stock screener for Haleon plc (HLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haleon plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haleon plc (HLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haleon plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.